Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Conversion of Human Induced Pluripotent Stem Cells (iPSCs) into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors.

Garone MG, de Turris V, Soloperto A, Brighi C, De Santis R, Pagani F, Di Angelantonio S, Rosa A.

J Vis Exp. 2019 May 1;(147). doi: 10.3791/59321.

PMID:
31107442
2.

Mechanical Durotactic Environment Enhances Specific Glioblastoma Cell Responses.

Palamà IE, D'Amone S, Ratano P, Donatelli A, Liscio A, Antonacci G, Testini M, Di Angelantonio S, Ragozzino D, Cortese B.

Cancers (Basel). 2019 May 9;11(5). pii: E643. doi: 10.3390/cancers11050643.

3.

Microglia shape presynaptic properties at developing glutamatergic synapses.

Basilico B, Pagani F, Grimaldi A, Cortese B, Di Angelantonio S, Weinhard L, Gross C, Limatola C, Maggi L, Ragozzino D.

Glia. 2019 Jan;67(1):53-67. doi: 10.1002/glia.23508. Epub 2018 Nov 11.

PMID:
30417584
4.

Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model.

Grimaldi A, Brighi C, Peruzzi G, Ragozzino D, Bonanni V, Limatola C, Ruocco G, Di Angelantonio S.

Cell Death Dis. 2018 Jun 7;9(6):685. doi: 10.1038/s41419-018-0740-5.

5.

Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma.

Grimaldi A, D'Alessandro G, Di Castro MA, Lauro C, Singh V, Pagani F, Sforna L, Grassi F, Di Angelantonio S, Catacuzzeno L, Wulff H, Limatola C, Catalano M.

Sci Rep. 2018 May 16;8(1):7654. doi: 10.1038/s41598-018-25940-5.

6.

Direct conversion of human pluripotent stem cells into cranial motor neurons using a piggyBac vector.

De Santis R, Garone MG, Pagani F, de Turris V, Di Angelantonio S, Rosa A.

Stem Cell Res. 2018 May;29:189-196. doi: 10.1016/j.scr.2018.04.012. Epub 2018 Apr 27.

7.

Environmental stimuli shape microglial plasticity in glioma.

Garofalo S, Porzia A, Mainiero F, Di Angelantonio S, Cortese B, Basilico B, Pagani F, Cignitti G, Chece G, Maggio R, Tremblay ME, Savage J, Bisht K, Esposito V, Bernardini G, Seyfried T, Mieczkowski J, Stepniak K, Kaminska B, Santoni A, Limatola C.

Elife. 2017 Dec 29;6. pii: e33415. doi: 10.7554/eLife.33415.

8.

ATP release during cell swelling activates a Ca2+-dependent Cl- current by autocrine mechanism in mouse hippocampal microglia.

Murana E, Pagani F, Basilico B, Sundukova M, Batti L, Di Angelantonio S, Cortese B, Grimaldi A, Francioso A, Heppenstall P, Bregestovski P, Limatola C, Ragozzino D.

Sci Rep. 2017 Jun 23;7(1):4184. doi: 10.1038/s41598-017-04452-8.

9.

The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells.

Garofalo S, Grimaldi A, Chece G, Porzia A, Morrone S, Mainiero F, D'Alessandro G, Esposito V, Cortese B, Di Angelantonio S, Trettel F, Limatola C.

J Neurosci. 2017 Apr 5;37(14):3926-3939. doi: 10.1523/JNEUROSCI.2296-16.2017. Epub 2017 Mar 14.

10.

TMEM16F Regulates Spinal Microglial Function in Neuropathic Pain States.

Batti L, Sundukova M, Murana E, Pimpinella S, De Castro Reis F, Pagani F, Wang H, Pellegrino E, Perlas E, Di Angelantonio S, Ragozzino D, Heppenstall PA.

Cell Rep. 2016 Jun 21;15(12):2608-15. doi: 10.1016/j.celrep.2016.05.039.

11.

Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases.

Lenzi J, Pagani F, De Santis R, Limatola C, Bozzoni I, Di Angelantonio S, Rosa A.

Stem Cell Res. 2016 Jul;17(1):140-7. doi: 10.1016/j.scr.2016.06.003. Epub 2016 Jun 8.

12.

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.

D'Alessandro G, Grimaldi A, Chece G, Porzia A, Esposito V, Santoro A, Salvati M, Mainiero F, Ragozzino D, Di Angelantonio S, Wulff H, Catalano M, Limatola C.

Oncotarget. 2016 May 24;7(21):30781-96. doi: 10.18632/oncotarget.8761.

13.

KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages.

Grimaldi A, D'Alessandro G, Golia MT, Grössinger EM, Di Angelantonio S, Ragozzino D, Santoro A, Esposito V, Wulff H, Catalano M, Limatola C.

Cell Death Dis. 2016 Apr 7;7:e2174. doi: 10.1038/cddis.2016.73.

14.

Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R.

Di Angelantonio S, Bertollini C, Piccinin S, Rosito M, Trettel F, Pagani F, Limatola C, Ragozzino D.

Front Cell Neurosci. 2015 Oct 12;9:409. doi: 10.3389/fncel.2015.00409. eCollection 2015.

15.

Defective microglial development in the hippocampus of Cx3cr1 deficient mice.

Pagani F, Paolicelli RC, Murana E, Cortese B, Di Angelantonio S, Zurolo E, Guiducci E, Ferreira TA, Garofalo S, Catalano M, D'Alessandro G, Porzia A, Peruzzi G, Mainiero F, Limatola C, Gross CT, Ragozzino D.

Front Cell Neurosci. 2015 Mar 31;9:111. doi: 10.3389/fncel.2015.00111. eCollection 2015.

16.

A role for intracellular zinc in glioma alteration of neuronal chloride equilibrium.

Di Angelantonio S, Murana E, Cocco S, Scala F, Bertollini C, Molinari MG, Lauro C, Bregestovski P, Limatola C, Ragozzino D.

Cell Death Dis. 2014 Oct 30;5:e1501. doi: 10.1038/cddis.2014.437.

17.

CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes.

Catalano M, Lauro C, Cipriani R, Chece G, Ponzetta A, Di Angelantonio S, Ragozzino D, Limatola C.

J Neuroimmunol. 2013 Oct 15;263(1-2):75-82. doi: 10.1016/j.jneuroim.2013.07.020. Epub 2013 Aug 8.

PMID:
23968561
18.

Transient increase in neuronal chloride concentration by neuroactive aminoacids released from glioma cells.

Bertollini C, Murana E, Mosca L, D'Erme M, Scala F, Francioso A, Catalano M, Limatola C, Bregestovski P, Di Angelantonio S, Ragozzino D.

Front Mol Neurosci. 2012 Nov 26;5:100. doi: 10.3389/fnmol.2012.00100. eCollection 2012.

19.

Adenosine A2A receptor induces protein kinase A-dependent functional modulation of human (alpha)3(beta)4 nicotinic receptor.

Di Angelantonio S, Piccioni A, Moriconi C, Trettel F, Cristalli G, Grassi F, Limatola C.

J Physiol. 2011 Jun 1;589(Pt 11):2755-66. doi: 10.1113/jphysiol.2011.207282. Epub 2011 Apr 11.

20.

Mutant human β4 subunit identified in amyotrophic lateral sclerosis patients impairs nicotinic receptor function.

Moriconi C, Di Angelantonio S, Piccioni A, Trettel F, Sabatelli M, Grassi F.

Pflugers Arch. 2011 Feb;461(2):225-33. doi: 10.1007/s00424-010-0905-2. Epub 2010 Nov 25.

PMID:
21107856
21.

Lack of dystrophin functionally affects α3β2/β4-nicotinic acethylcholine receptors in sympathetic neurons of dystrophic mdx mice.

Di Angelantonio S, De Stefano ME, Piccioni A, Lombardi L, Gotti C, Paggi P.

Neurobiol Dis. 2011 Feb;41(2):528-37. doi: 10.1016/j.nbd.2010.10.024. Epub 2010 Nov 5.

PMID:
21056666
22.

CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes.

Piccinin S, Di Angelantonio S, Piccioni A, Volpini R, Cristalli G, Fredholm BB, Limatola C, Eusebi F, Ragozzino D.

J Neuroimmunol. 2010 Jul 27;224(1-2):85-92. doi: 10.1016/j.jneuroim.2010.05.012. Epub 2010 Jun 8.

PMID:
20570369
23.

Chemokines and chemokine receptors in the nervous system. Rome, 24/25 October, 2009, 2nd workshop.

Trettel F, Di Angelantonio S, Limatola C, Ransohoff RM.

J Neuroimmunol. 2010 Jul 27;224(1-2):1-7. doi: 10.1016/j.jneuroim.2010.05.001. Epub 2010 Jun 11. No abstract available.

PMID:
20541268
24.

Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis.

Sabatelli M, Eusebi F, Al-Chalabi A, Conte A, Madia F, Luigetti M, Mancuso I, Limatola C, Trettel F, Sobrero F, Di Angelantonio S, Grassi F, Di Castro A, Moriconi C, Fucile S, Lattante S, Marangi G, Murdolo M, Orteschi D, Del Grande A, Tonali P, Neri G, Zollino M.

Hum Mol Genet. 2009 Oct 15;18(20):3997-4006. doi: 10.1093/hmg/ddp339. Epub 2009 Jul 23.

PMID:
19628475
25.

Chemokines and chemokine receptors in the nervous system Rome, 27/28 October, 2007.

Trettel F, Di Angelantonio S, Limatola C, Ransohoff RM.

J Neuroimmunol. 2008 Jul 31;198(1-2):1-8. doi: 10.1016/j.jneuroim.2008.04.006. Epub 2008 May 29. Review. No abstract available.

PMID:
18511134
26.

Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons.

Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L, Brusadin V, Ragozzino D, Limatola C.

J Immunol. 2008 Jun 1;180(11):7590-6.

27.

The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.

Palma E, Ragozzino D, Di Angelantonio S, Mascia A, Maiolino F, Manfredi M, Cantore G, Esposito V, Di Gennaro G, Quarato P, Miledi R, Eusebi F.

Epilepsia. 2007 Oct;48(10):1842-9. Epub 2007 May 23.

28.

Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons.

Ragozzino D, Di Angelantonio S, Trettel F, Bertollini C, Maggi L, Gross C, Charo IF, Limatola C, Eusebi F.

J Neurosci. 2006 Oct 11;26(41):10488-98.

29.

Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory.

Palma E, Amici M, Sobrero F, Spinelli G, Di Angelantonio S, Ragozzino D, Mascia A, Scoppetta C, Esposito V, Miledi R, Eusebi F.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8465-8. Epub 2006 May 18. Erratum in: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11814.

30.

Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.

Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.

Br J Pharmacol. 2005 Dec;146(8):1096-109.

31.

Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy.

Ragozzino D, Palma E, Di Angelantonio S, Amici M, Mascia A, Arcella A, Giangaspero F, Cantore G, Di Gennaro G, Manfredi M, Esposito V, Quarato PP, Miledi R, Eusebi F.

Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15219-23. Epub 2005 Oct 10.

32.

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity.

Limatola C, Lauro C, Catalano M, Ciotti MT, Bertollini C, Di Angelantonio S, Ragozzino D, Eusebi F.

J Neuroimmunol. 2005 Sep;166(1-2):19-28.

PMID:
16019082
33.

Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels.

Federici M, Geracitano R, Tozzi A, Longone P, Di Angelantonio S, Bengtson CP, Bernardi G, Mercuri NB.

Mol Pharmacol. 2005 Apr;67(4):1283-90. Epub 2005 Jan 11.

PMID:
15644497
34.

Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block.

Di Angelantonio S, Bernardi G, Mercuri NB.

Neurosci Lett. 2004 Oct 21;369(3):208-13.

PMID:
15464266
35.

Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain.

Palma E, Ragozzino DA, Di Angelantonio S, Spinelli G, Trettel F, Martinez-Torres A, Torchia G, Arcella A, Di Gennaro G, Quarato PP, Esposito V, Cantore G, Miledi R, Eusebi F.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10183-8. Epub 2004 Jun 24.

36.

Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones.

Di Angelantonio S, Bernardi G, Mercuri NB.

Br J Pharmacol. 2004 Feb;141(4):644-52. Epub 2004 Jan 26.

37.

Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Di Angelantonio S, Giniatullin R, Costa V, Sokolova E, Nistri A.

Br J Pharmacol. 2003 Jul;139(6):1061-73. Review.

38.

Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells.

Di Angelantonio S, Matteoni C, Fabbretti E, Nistri A.

Eur J Neurosci. 2003 Jun;17(11):2313-22.

PMID:
12814364
39.

Enhancement of neuronal nicotinic receptor activity of rat chromaffin cells by a novel class of peptides.

Nistri A, Di Angelantonio S.

Ann N Y Acad Sci. 2002 Oct;971:100-7.

PMID:
12438099
40.
41.

Calibration of agonist concentrations applied by pressure pulses or via rapid solution exchanger.

Di Angelantonio S, Nistri A.

J Neurosci Methods. 2001 Sep 30;110(1-2):155-61.

PMID:
11564536
42.

Rapid relief of block by mecamylamine of neuronal nicotinic acetylcholine receptors of rat chromaffin cells in vitro: an electrophysiological and modeling study.

Giniatullin RA, Sokolova EM, Di Angelantonio S, Skorinkin A, Talantova MV, Nistri A.

Mol Pharmacol. 2000 Oct;58(4):778-87.

PMID:
10999948
43.
44.

Calcitonin gene-related peptide rapidly downregulates nicotinic receptor function and slowly raises intracellular Ca2+ in rat chromaffin cells in vitro.

Giniatullin R, Di Angelantonio S, Marchetti C, Sokolova E, Khiroug L, Nistri A.

J Neurosci. 1999 Apr 15;19(8):2945-53.

Supplemental Content

Loading ...
Support Center